Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Medically reviewed by Kashif J. Piracha, MD Medically reviewed by Kashif J. Piracha, MD Acute kidney failure, now known as ...

Columnist Caroline Gainer is concerned about a couple of results from her recent annual wellness visit that could suggest ...

The surprise finding hints that anti–acid reflux therapy may provide benefit in COPD, possibly by reducing micro-aspirations, ...

The following is a summary of “Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease ...

A higher abundance of monocyte-derived alveolar macrophages significantly correlated with worse lung fibrosis in RPRA ...

Long COVID development may be influenced by severity of the initial COVID-19 illness and pre-existing respiratory conditions, including COPD and OSA.

Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...

Exacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and ...

Krunal Patel, MD, Temple University Hospital, highlights CHEST 2024 data revealing why timing matters with acute pulmonary embolism (PE) intervention.

The prevalence of PH was 12.8% in those hospitalized in 2018 with left heart disease, a lower percentage than found in previous research.